Furukawa Kenei, Shiba Hiroaki, Shirai Yoshihiro, Horiuchi Takashi, Iwase Ryota, Haruki Koichiro, Fujiwara Yuki, Misawa Takeyuki, Yanaga Katsuhiko
Department of Surgery, Jikei University School of Medicine, Tokyo, Japan
Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
Anticancer Res. 2015 Sep;35(9):5079-83.
BACKGROUND/AIM: Patients with obstructive jaundice due to cancer of the pancreatic head often undergo preoperative endoscopic biliary drainage (EBD). The aim of the study was to evaluate the long-term impact of preoperative EBD following pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma.
We studied 106 patients who underwent PD for pancreatic ductal adenocarcinoma between May 2000 and November 2013 at the Jikei University Hospital. We retrospectively examined perioperative findings as predictors of prognosis and the relationship between preoperative EBD and recurrence rate as well as overall survival.
In univariate analysis, significant factors associated with poor disease-free survival consisted of the presence of EBD (p=0.0213), poor tumor differentiation (p=0.0023) and tumor-node-metastasis (TNM) classification IV (p=0.0027), while significant factors associated with poor overall survival consisted of the presence of EBD (p=0.0047), poor tumor differentiation (p<0.0001), TNM classification IV (p=0.0031) and microscopic or macroscopic residual tumor (p=0.0184). In multivariate analysis, poor tumor differentiation (p=0.0033) and TNM classification IV (p=0.0020) were independent factors for poor disease-free survival, while the presence of EBD (p=0.0435), poor tumor differentiation (p=0.0009), TNM classification IV (p=0.0447) and microscopic or macroscopic residual tumor (p=0.0184) were independent factors for poor overall survival.
Preoperative EBD may have a negative impact on prognosis after PD for pancreatic ductal adenocarcinoma.
背景/目的:胰头癌所致梗阻性黄疸患者常需接受术前内镜下胆道引流(EBD)。本研究旨在评估胰十二指肠切除术(PD)治疗胰腺导管腺癌术前EBD的长期影响。
我们研究了2000年5月至2013年11月间在慈惠会医科大学医院接受PD治疗胰腺导管腺癌的106例患者。我们回顾性分析了围手术期结果作为预后预测指标,以及术前EBD与复发率和总生存率之间的关系。
单因素分析中,与无病生存期差相关的显著因素包括EBD的存在(p = 0.0213)、肿瘤分化差(p = 0.0023)和肿瘤-淋巴结-转移(TNM)分类为IV期(p = 0.0027),而与总生存期差相关的显著因素包括EBD的存在(p = 0.0047)、肿瘤分化差(p < 0.0001)、TNM分类为IV期(p = 0.0031)和镜下或肉眼残留肿瘤(p = 0.0184)。多因素分析中,肿瘤分化差(p = 0.0033)和TNM分类为IV期(p = 0.0020)是无病生存期差的独立因素,而EBD的存在(p = 0.0435)、肿瘤分化差(p = 0.0009)、TNM分类为IV期(p = 0.0447)和镜下或肉眼残留肿瘤(p = 0.0184)是总生存期差的独立因素。
术前EBD可能对胰腺导管腺癌PD术后的预后产生负面影响。